Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample
Epidemiology and Health · 2023
DOI: 10.4178/epih.e2023075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epidemiology and Health, 2023. Verfasst von Jina Han und 55 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, Korea. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institutes of Health of the Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
OBJECTIVES: We estimated the population prevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including unreported infections, through a Korea Seroprevalence Study of Monitoring of SARS-CoV-2 Antibody Retention and Transmission (K-SEROSMART) in 258 communities throughout Korea.METHODS: In August 2022, a survey was conducted among 10,000 household members aged 5 years and older, in households selected through two stage probability random sampling. During face-to-face household interviews, participants self-reported their health status, COVID-19 diagnosis and vaccination history, and general characteristics. Subsequently, participants visited a community health center or medical clinic for blood sampling. Blood samples were analyzed for the presence of antibodies to spike proteins (anti-S) and antibodies to nucleocapsid proteins (anti-N) SARS-CoV-2 proteins using an electrochemiluminescence immunoassay. To estimate the population prevalence, the PROC SURVEYMEANS statistical procedure was employed, with weighting to reflect demographic data from July 2022.RESULTS: In total, 9,945 individuals from 5,041 households were surveyed across 258 communities, representing all basic local governments in Korea. The overall population-adjusted prevalence rates of anti-S and anti-N were 97.6% and 57.1%, respectively. Since the Korea Disease Control and Prevention Agency has reported a cumulative incidence of confirmed cases of 37.8% through July 31, 2022, the proportion of unreported infections among all COVID-19 infection was suggested to be 33.9%.CONCLUSIONS: The K-SEROSMART represents the first nationwide, community-based seroepidemiologic survey of COVID-19, confirming that most individuals possess antibodies to SARS-CoV-2 and that a significant number of unreported cases existed. Furthermore, this study lays the foundation for a surveillance system to continuously monitor transmission at the community level and the response to COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Medicine and Public Health, Ajou University School of Medicine, Suwon, Korea.
- National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
- Institute of Health and Environment, Seoul National University, Seoul, Korea.
- Department of Nursing, Kyungmin University, Uijeongbu, Korea.
- Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, Korea.
- Gallup Korea, Seoul, Korea.
Förderung
- National Institutes of Health of the Korea Disease Control and Prevention Agency
Zitieren
APA
Han, J., Baek, H. J., Noh, E., Yoon, K., Kim, J. A., Ryu, S., Lee, K. O., Park, N. Y., Jung, E., Kim, S., Lee, H., Hwang, Y. S., Jung, J., Lee, H. J., Cho, S. I., Oh, S., Kim, M., Oh, C. M., Yu, B., …, & Kim, D. H. (2023). Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample. Epidemiology and Health. https://doi.org/10.4178/epih.e2023075
Vancouver
Han J, Baek HJ, Noh E, Yoon K, Kim JA, Ryu S, et al. Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample. Epidemiology and Health. 2023. doi:10.4178/epih.e2023075
BibTeX
@article{Han2023,
author = {Han, Jina and Baek, Hye Jin and Noh, Eunbi and Yoon, Kyuhyun and Kim, Jung Ae and Ryu, Sukhyun and Lee, Kay O and Park, No Yai and Jung, Eunok and Kim, Sangil and Lee, Hyukmin and Hwang, Yoo-Sung and Jung, Jaehun and Lee, Hun Jae and Cho, Sung-Il and Oh, Sangcheol and Kim, Migyeong and Oh, Chang-Mo and Yu, Byengchul and Hong, Young-Seoub and Kim, Keonyeop and Jung, Sun Jae and Han, Mi Ah and Lee, Moo-Sik and Lee, Jung-Jeung and Hwangbo, Young and Yim, Hyeon Woo and Kim, Yu-Mi and Lee, Joongyub and Lee, Weon-Young and Park, Jae-Hyun and Oh, Sungsoo and Jo, Heui Sug and Kim, Hyeongsu and Kang, Gilwon and Nam, Hae-Sung and Lee, Ju-Hyung and Oh, Gyung-Jae and Shin, Min-Ho and Ryu, Soyeon and Hwang, Tae-Yoon and Park, Soon-Woo and Kim, Sang Kyu and Seol, Roma and Park, Ki-Soo and Kim, Su Young and Kwon, Jun-Wook and Kim, Sung Soon and Kim, Byoungguk and Lee, June-Woo and Jang, Eun Young and Kim, Ah-Ra and Nam, Jeonghyun and Korea Community Health Survey Group, Korea Community Health Survey Group and Lee, Soon Young and Kim, Dong-Hyun},
title = {Korea Seroprevalence Study of Monitoring of SARS-COV-2 Antibody Retention and Transmission (K-SEROSMART): findings from national representative sample},
journal = {Epidemiology and Health},
year = {2023},
doi = {10.4178/epih.e2023075}
}
EUVIMED